• Kevin Greenhalgh
    Good to hear $IMUC is getting back on the horse. First patient has been treated with ICT-121 in phase I trial.
    Reply (3)
    • oneotherfool: It's up 18% AH. Was this not expected? Just trying to understand the excitement behind the rise.
    • oneotherfool: Reading through the PR, it's probably the positive comments about the phase II trial of ICT-107.
    • Robbster: Think the psychology here is that $IMUC was closely watched, high hopes, BIG drop, so any + news can influence at sub $1 pp. I'm holding.